Investor profile
Clay Capital has backed 3 European tech companies across 3 funding rounds between 2024 and 2025, joining rounds totalling €93M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Infinite Roots (Mushlabs) | Germany | 1 | €53M |
| Abolis Biotechnologies | France | 1 | €35M |
| Scindo | UK | 1 | €4.5M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Infinite Roots (Mushlabs) | Series B | €53M | 2024-01 |
| Abolis Biotechnologies | Other | €35M | 2024-09 |
| Scindo | Other | €4.5M | 2025-09 |
